Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial compared tapentadol extended-release with placebo in adults with chronic painful diabetic peripheral neuropathy; the study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Nucynta ER (tapentadol extended-release)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Diabetic Peripheral Neuropathy | Phase 3 | Status: COMPLETED | Results posted: 2012-05-14